Current role
Biotechnology · Healthcare
CEO, Board Member
2026-06-10–present
Michael A. Metzger
Board Member
Syndax Pharmaceuticals Inc (SNDX)Equibles does not estimate personal net worth.
Get an email with a short summary when Syndax Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get SNDX alertsAbout Michael A. Metzger
Michael A. Metzger is recorded as Board Member at Syndax Pharmaceuticals Inc (SNDX) since June 10, 2026 and CEO at Syndax Pharmaceuticals Inc (SNDX). The newest filing on record that lists Michael A. Metzger as CEO at Syndax Pharmaceuticals Inc (SNDX) is dated April 30, 2026. The proxy statement of Syndax Pharmaceuticals Inc reports total compensation of $7,089,213 for Michael A. Metzger in fiscal 2025, including a base salary of $754,300. Disclosed compensation is on record for 6 fiscal years. Syndax Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Syndax Pharmaceuticals Inc includes Michael Metzger (CEO), Aaron A. Ondrey (CFO and Chief Accounting Officer), Daphne Karydas (CFO) and 5 others.
Affiliation history
-
Current
2026-06-10–present
-
Current
Start not stated–present
Last confirmed April 30, 2026
Company network
Leadership on record at Syndax Pharmaceuticals Inc
- Michael Metzger CEO
- Aaron A. Ondrey CFO, Chief Accounting Officer
- Daphne Karydas CFO
- Keith Goldan CFO
- Luke J. Albrecht General Counsel
- Aleksandra Rizo, M.D., Ph.D. Board Member
- Martin H. Huber, M.D. Board Member
- Pierre Legault Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Syndax Pharmaceuticals Inc (SNDX) | Chief Executive Officer | $754,300 | $7,089,213 |
| 2024 | Syndax Pharmaceuticals Inc (SNDX) | Chief Executive Officer | $715,000 | $7,707,176 |
| 2023 | Syndax Pharmaceuticals Inc (SNDX) | Chief Executive Officer | $678,400 | $9,127,419 |
| 2022 | Syndax Pharmaceuticals Inc (SNDX) | Chief Executive Officer | $640,000 | $4,113,476 |
| 2021 | Syndax Pharmaceuticals Inc (SNDX) | Chief Executive Officer | $594,104 | $3,333,905 |
| 2020 | Syndax Pharmaceuticals Inc (SNDX) | Chief Executive Officer | $576,800 | $1,949,531 |
Recent activity
No call appearances or filed executive changes recorded yet.